CNXC (Concentrix Corporation Common Stock) Stock Analysis - Hedge Fund Holdings
Concentrix Corporation Common Stock (CNXC) is a publicly traded Technology sector company. As of May 21, 2026, CNXC trades at $25.15 with a market cap of $1.46B and a P/E ratio of -1.18. CNXC moved +2.53% today. Year to date, CNXC is -41.60%; over the trailing twelve months it is -55.65%. Its 52-week range spans $22.05 to $66.00. Analyst consensus is strong buy with an average price target of $44.33. Rallies surfaces CNXC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns CNXC stock?
Hedge funds tracked by Rallies that own CNXC include Bridgewater Associates, Centerbook Partners, and Mangrove Partners. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Concentrix Corporation Common Stock.
CNXC Key Metrics
Key financial metrics for CNXC
Metric
Value
Price
$25.15
Market Cap
$1.46B
P/E Ratio
-1.18
EPS
$-21.07
Dividend Yield
0.36%
52-Week High
$66.00
52-Week Low
$22.05
Volume
23
Avg Volume
0
Revenue (TTM)
$9.95B
Net Income
$-1.33B
Gross Margin
34.45%
Top Hedge Funds Holding CNXC
Bridgewater Associates holds 145.80K shares of CNXC, changed -11.28% as of Dec 31, 2025.
Centerbook Partners holds 20.51K shares of CNXC, changed +15.56% as of Dec 31, 2025.
Mangrove Partners holds 5.48K shares of CNXC, changed +0.00% as of Mar 31, 2025.
Hedge funds tracked by Rallies that own CNXC include Bridgewater Associates, Centerbook Partners, and Mangrove Partners. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Concentrix Corporation Common Stock.
Does Rallies show 13F holders for CNXC?
Yes. Rallies tracks hedge fund and 13F ownership data for CNXC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is CNXC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CNXC. It does not provide personalized investment advice.